Brain cancer research is going to focus tremendously on glioblastoma and for all of the right reasons. It is one of the most important names to consider when it comes to this particular field, which is something that you can figure out in due time. Seeing as how treatment may be troublesome to find, though, what if I were to tell you that a tandem of drugs can bring about certain degrees of success? I believe that it is a point to take into consideration when considering such a serious ailment.
US News and World Report put up a written piece that spoke about the idea of treatment in terms of glioblastoma. It seems to be one of the greatest goals that is being worked to, which is especially true when considering how common - not to mention aggressive - this particular growth can be. The University of Zurich stated that the condition, at this point, is "virtually incurable." However, it seems as though a unique drug therapy could potentially prove to be one of the most useful in the long term.
The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?
To me, this is one of the best cases that can be taken into account and I do not think that anyone in the realm of brain cancer research can overlook this. This is especially true when you take into consideration that the T cells, thanks to the incorporation of another drug, can be halted in terms of regulation. The way that this could prove beneficial is through the survival rate boosting from 25% to 80%. It's a great point to consider, which is especially true for organizations along the lines of V-A-B-C.
Even if this procedure does not prove to be helpful in the long term, it is clear that there are possibilities that exist. They have to be able to come about or else the level of brain cancer research seen is not going to be nearly as tremendous as it should be. The drug combination spoken about here has proven itself to be especially noteworthy, which is something that is hard to overlook. It is important to keep this in mind so that, in time, other strategies can come into effect.
US News and World Report put up a written piece that spoke about the idea of treatment in terms of glioblastoma. It seems to be one of the greatest goals that is being worked to, which is especially true when considering how common - not to mention aggressive - this particular growth can be. The University of Zurich stated that the condition, at this point, is "virtually incurable." However, it seems as though a unique drug therapy could potentially prove to be one of the most useful in the long term.
The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?
To me, this is one of the best cases that can be taken into account and I do not think that anyone in the realm of brain cancer research can overlook this. This is especially true when you take into consideration that the T cells, thanks to the incorporation of another drug, can be halted in terms of regulation. The way that this could prove beneficial is through the survival rate boosting from 25% to 80%. It's a great point to consider, which is especially true for organizations along the lines of V-A-B-C.
Even if this procedure does not prove to be helpful in the long term, it is clear that there are possibilities that exist. They have to be able to come about or else the level of brain cancer research seen is not going to be nearly as tremendous as it should be. The drug combination spoken about here has proven itself to be especially noteworthy, which is something that is hard to overlook. It is important to keep this in mind so that, in time, other strategies can come into effect.
About the Author:
Visit Voices Against Brain Cancer if you are seeking some more information about brain cancer awareness and research.. Also published at Brain Cancer Research & Understanding A Particular Hybrid.
0 comments:
Post a Comment